- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03880955
A Post-Market Clinical Evaluation of the ReUnion Reverse Shoulder Arthroplasty (RSA) System
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Illinois
-
Peoria, Illinois, United States, 61605
- Great Plains Orthopedics
-
-
South Carolina
-
Greenville, South Carolina, United States, 29615
- Steadman Hawkins Clinic of the Carolinas
-
-
Tennessee
-
Nashville, Tennessee, United States, 37209
- Tennessee Orthopaedic Alliance
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Subject is willing to sign the informed consent.
- Subject is willing and able to comply with postoperative scheduled clinical and radiographic evaluations.
- Subject is male or non-pregnant female and 18 years or older at the time of surgery.
Subject's joint has gross rotator cuff deficiency, a functional deltoid muscle and is anatomically and structurally suited to receive the implant and subject has one or more of the following:
- Painful, disabling joint disease of the shoulder resulting from degenerative arthritis or rheumatoid arthritis
- Failed previous shoulder joint replacement
Exclusion Criteria:
- Subject has an active or suspected latent infection in or about the shoulder joint.
- Subject has mental or neuromuscular disorder which would create an unacceptable risk of prosthesis instability, prosthesis fixation failure or complications in postoperative care.
- Subject has bone stock compromised by disease, infection or prior implantation which cannot provide adequate support and/or fixation to the prosthesis.
- Subject has anticipated activities which would impose high stresses on the prosthesis and its fixation.
- Subject is obese such that he/she produces a load on the prosthesis which can lead to failure of fixation of the device or to failure of the device itself.
- Subject has concomitant disease(s) which may significantly affect the clinical outcome.
- Subject has traumatic or pathologic fracture of the proximal humerus
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
ReUnion RSA System
Subject's joint has gross rotator cuff deficiency, a functional deltoid muscle and is anatomically and structurally suited to receive the implant and subject has one or more of the following:
|
The ReUnion RSA System is designed as a reverse total shoulder endoprosthesis to address unrepairable gross rotator cuff tear, rotator cuff arthropathy with pseudoparalysis of the shoulder joint, advanced arthritic and rheumatic disorders affecting the shoulder joint, and failed previous shoulder arthroplasty.
The ReUnion RSA System is comprised of a Humeral Cup, Humeral Insert, Glenosphere, Glenoid Baseplate and Screws.
The intended purposes of the ReUnion RSA System are to achieve pain relief, improvement of range of motion and restoration or improvement of the shoulder function while ensuring long-term replacement of the shoulder joint with sufficient stability of all endoprosthesis components.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
American Shoulder and Elbow Surgeons (ASES) Shoulder Score
Time Frame: 24 Months
|
This is a mixed outcome reporting measure, applicable for use in patients with shoulder pathology regardless of diagnosis and consists of a pain visual analog scale (VAS) and 10 functional questions.The primary endpoint of the clinical investigation is to demonstrate non-inferiority of the device to the selected literature controls, as measured by the ASES Shoulder Score at 24 Months post-operative
|
24 Months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Safety will be measured by capturing the incidence rate of device-related intra-operative adverse events.
Time Frame: 10 years
|
Secondary outcome measures to assess safety by capturing the incidence rate of device-related intra-operative adverse events.
|
10 years
|
Safety will be measured by capturing the incidence rate of device-related post-operative adverse events.
Time Frame: 10 years
|
Secondary outcome measures to assess safety by capturing the incidence rate of device-related post-operative adverse events.
|
10 years
|
Efficacy will be measured by monitoring all implant survivorship in all subjects who have the reverse total shoulder endoprosthesis with the ReUnion RSA System.
Time Frame: 10 years
|
Secondary outcome measures to assess efficacy by monitoring all implant survivorship in all subjects who have the reverse total shoulder endoprosthesis with the ReUnion RSA System.
|
10 years
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Rebecca Gibson, Stryker Trauma and Extremities
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- ReUnion RSA Study
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Shoulder Arthroplasty
-
Hospital for Special Surgery, New YorkRecruiting
-
Arthrex, Inc.RecruitingShoulder ArthroplastyUnited States, Switzerland, Germany
-
Universitaire Ziekenhuizen KU LeuvenActive, not recruiting
-
Duke UniversityCompletedShoulder ArthroplastyUnited States
-
Stryker Trauma GmbHTerminated
-
Limacorporate S.p.aIqvia Pty LtdNot yet recruitingArthroplasty | Replacement | Shoulder
-
University of WashingtonRecruiting
-
Universiteit AntwerpenUniversity Hospital, AntwerpRecruitingArthroplasty, Replacement, ShoulderBelgium
-
DePuy OrthopaedicsNot yet recruiting
-
University of MinnesotaRecruitingTotal Shoulder ArthroplastyUnited States
Clinical Trials on ReUnion RSA System
-
Stryker Trauma GmbHTerminatedArthroplasty | Hemiarthroplasty | Shoulder PainUnited States
-
Stryker Trauma GmbHTerminated
-
Mayo ClinicStryker NordicCompletedGlenohumeral Joint DegenerationUnited States
-
Mayo ClinicCompletedArthritis | Shoulder Pain | Inflammatory Arthritis | Shoulder Osteoarthritis | Shoulder Arthritis | Shoulder Arthropathy Associated With Other Conditions | Arthropathy Shoulder | Necrosis of BoneUnited States
-
Lovisenberg Diakonale HospitalRecruitingArthroplasty Complications | Shoulder OsteoarthritisNorway
-
Massachusetts General HospitalUnknownDistal Femur FracturesUnited States
-
Zimmer BiometActive, not recruitingAvascular Necrosis | Inflammatory Arthritis | Osteoarthritis, Hip | Post-Traumatic Osteoarthritis of HipAustria, France, Germany, Spain
-
Istituto Ortopedico GaleazziRecruitingKnee Osteoarthritis | Knee Arthropathy | Aseptic LooseningItaly
-
State University of New York - Upstate Medical...WithdrawnAssess Motion in Flexion/Extension and Lateral Bending of the Lumbar Vertebrae in Vivo Following Motion Sparing Surgery Using Radiostereometric Analysis (RSA.)United States
-
Lovisenberg Diakonale HospitalHaukeland University Hospital; Sykehuset Telemark; University Hospital, AkershusRecruitingShoulder Osteoarthritis | Arthroplasty, Replacement, ShoulderNorway